Skip to contents

Frederick J. Schoen, MD, PhD
Senior Pathologist, Brigham and Women's Hospital
Professor of Pathology and Health Sciences and Technology, Harvard Medical School
Executive Vice Chairman, Department of Pathology, Brigham and Women’s Hospital

Brigham and Women's Hospital
Department of Pathology
75 Francis Street
Boston, MA 02115

Edit Profile

Research Narrative:

We investigate the functional structure and cell/matrix biology, and tissue engineering of heart valves. The objectives of these studies are to understand the mechanisms of normal valve functional dynamics and how these are disrupted in valve disease, and the limitations to the success of currently available prosthetic devices.  Our studies provide input to the development of improved management strategies for native and prosthetic valve disease and potentially new medical devices.

Specifically, we study healthy and diseased native heart valves and heart valve prostheses retrieved at reoperation or post-mortem examination.  Ongoing investigations of native valves explore the mechanisms of regulation of valvular interstitial cell phenotypes and collagenous matrix under various conditions of altered mechanical environment and patient age throughout life and approaches to the creation of a living valve replacement through in-vitro and in-vivo tissue engineering approaches based on an understanding of valve developmental biology, valvular cell and matrix biology and valve responses to injury.   Studies of valve substitutes are designed to establish failure modes, pathologic correlations of clinical function and other details of patient/prosthesis interactions.  In preclinical studies, we analyze new valve configurations with modified and potentially improved materials or designs implanted in animals as actual valve replacements in order to evaluate the long-term efficacy and safety of these designs, to predict complications, and to develop new materials and configurations.  We also study the mechanisms of particular failure modes associated with degeneration of bioprostheses in experimental animal model systems.  For example, our experimental studies of calcification, the major cause of failure of contemporary bioprosthetic valves, have provided the correlation of observations on human material with experimental data and hypotheses, delineating clinicopathologic correlates of failure, the role in calcification of key physiological variables and structural determinants.  We are also participating in the development of innovative heart valve replacements, including devices that can be implanted percutaneously through a catheter, and engineered tissue heart valves.  

Selected Publications

Rabkin-Aikawa E, Aikawa M, Farber, M, Kratz, JR, Garcia-Cardena G, Kouchoukos NT, Mitchell MB, Jonas RA, Schoen FJ:  Clinical pulmonary autograft valves: Pathological evidence of adaptive remodeling in the aortic site.  J Thorac Cardiovasc Surg. 2004; 128:552-562.

Sutherland FWH, Perry TE, Yu Y, Sherwood MC, Rabkin E, Masuda Y, Garcia GA, McLellan DL, Engelmayr GC, Sacks MS, Schoen FJ, Mayer JE.  From stem cells to viable autologous semilunar heart valve.  Circulation 2005; 111:2783-2791.

Schoen FJ, Levy RJ.  Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005; 79:1072-1080.

Mendelson KM, Schoen FJ:  Heart valve tissue engineering: Concepts, approaches, progress, and challenges. Ann Biomed Engin 2006; 34:1799-1819.

Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, Schoen FJ, Bischoff J: Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to VEGF-A and TGFβ2.  Circ Res 2006; 99:861-869.

Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, Schoen FJ:  Human semilunar cardiac valve remodeling by activated cells from fetus to adult: Implications for postnatal adaptation, pathology and tissue engineering.  Circulation 2006; 113:1344-1352.

Mikos A, Herring SW, Elisseeff J, Lu HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A, Kaplan DL, Vunjak-Novakovic G: Engineering complex tissues.  Tissue Eng, 2006, 12:3307-3339.

Schoen FJ.  Evolving concepts of cardiac valve dynamics.   The continuum of development, functional structure, pathobiology and tissue engineering.  Circulation (submitted)

Investigative Interests

Biomaterials-tissue interactions, medical devices and tissue engineering: cardiovascular pathology; CIMIT Site Miner at BWH


Publications (Pulled from Harvard Catalyst Profiles):

1. Zhang BL, Bianco RW, Schoen FJ. Preclinical Assessment of Cardiac Valve Substitutes: Current Status and Considerations for Engineered Tissue Heart Valves. Front Cardiovasc Med. 2019; 6:72.

2. El-Kurdi M, Soletti L, McGrath J, Linhares S, Rousselle S, Greisler H, Edelman E, Schoen FJ. Functional remodeling of an electrospun polydimethylsiloxane-based polyether urethane external vein graft support device in an ovine model. J Biomed Mater Res A. 2019 Oct; 107(10):2135-2149.

3. Schoen FJ, Mitchell RN. 2019 Society for Cardiovascular Pathology Distinguished Achievement Award Recipient -- Gayle L. Winters, M.D. Cardiovasc Pathol. 2019 May 06; 42:4-5.

4. Zhao H, Zhang H, Schoen FJ, Schachter SC, Feng HJ. Repeated generalized seizures can produce calcified cardiac lesions in DBA/1 mice. Epilepsy Behav. 2019 Jun; 95:169-174.

5. Hutcheson JD, Goergen CJ, Schoen FJ, Aikawa M, Zilla P, Aikawa E, Gaudette GR. After 50 Years of Heart Transplants: What Does the Next 50 Years Hold for Cardiovascular Medicine? A Perspective From the International Society for Applied Cardiovascular Biology. Front Cardiovasc Med. 2019; 6:8.

6. Yu M, Ortega CA, Si K, Molinaro R, Schoen FJ, Leitao RFC, Xu X, Mahmoudi M, Ahn S, Liu J, Saw PE, Lee IH, Brayner MMB, Lotfi A, Shi J, Libby P, Jon S, Farokhzad OC. Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery. Theranostics. 2018; 8(21):6008-6024.

7. Brugmans M, Serrero A, Cox M, Svanidze O, Schoen FJ. Morphology and mechanisms of a novel absorbable polymeric conduit in the pulmonary circulation of sheep. Cardiovasc Pathol. 2019 Jan - Feb; 38:31-38.

8. Mitsouras D, Tao M, de Vries MR, Trocha K, Miranda OR, Vemula PK, Ding K, Imanzadeh A, Schoen FJ, Karp JM, Ozaki CK, Rybicki FJ. Early animal model evaluation of an implantable contrast agent to enhance magnetic resonance imaging of arterial bypass vein grafts. Acta Radiol. 2018 Sep; 59(9):1074-1081.

9. Cirka HA, Uribe J, Liang V, Schoen FJ, Billiar KL. Reproducible in vitro model for dystrophic calcification of cardiac valvular interstitial cells: insights into the mechanisms of calcific aortic valvular disease. Lab Chip. 2017 02 28; 17(5):814-829.

10. Ayoub S, Ferrari G, Gorman RC, Gorman JH, Schoen FJ, Sacks MS. Heart Valve Biomechanics and Underlying Mechanobiology. Compr Physiol. 2016 09 15; 6(4):1743-1780.